Microba Life Sciences Ltd (MAP) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.184x

Based on the latest financial reports, Microba Life Sciences Ltd (MAP) has a cash flow conversion efficiency ratio of -0.184x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-5.70 Million ≈ $-4.04 Million USD) by net assets (AU$31.08 Million ≈ $21.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Microba Life Sciences Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Microba Life Sciences Ltd - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how Microba Life Sciences Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Microba Life Sciences Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Microba Life Sciences Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Chemring Group PLC LSE:CHG	0.176x
Oylum Sinai Yatirimlar AS IS:OYLUM	0.179x
Marwynn Holdings, Inc. Common stock NASDAQ:MWYN	-0.332x
Rodrigo Tekstil Sanayi ve Ticaret AS IS:RODRG	0.051x
Garanti Yatirim Ortakligi AS IS:GRNYO	0.026x
Vinpai SAS PA:ALVIN	3.105x
Green River Holding Co Ltd TWO:8444	-0.174x
Greenvale Energy Ltd AU:GRV	-0.058x

Annual Cash Flow Conversion Efficiency for Microba Life Sciences Ltd (2018–2024)

The table below shows the annual cash flow conversion efficiency of Microba Life Sciences Ltd from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see Microba Life Sciences Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$32.49 Million ≈ $22.99 Million	AU$-12.01 Million ≈ $-8.50 Million	-0.370x	+2.12%
2023-12-31	AU$41.22 Million ≈ $29.16 Million	AU$-15.57 Million ≈ $-11.01 Million	-0.378x	-18.01%
2022-12-31	AU$38.72 Million ≈ $27.40 Million	AU$-12.39 Million ≈ $-8.77 Million	-0.320x	-2.72%
2021-12-31	AU$33.54 Million ≈ $23.73 Million	AU$-10.45 Million ≈ $-7.39 Million	-0.312x	+35.20%
2020-12-31	AU$14.94 Million ≈ $10.57 Million	AU$-7.18 Million ≈ $-5.08 Million	-0.481x	+14.32%
2019-12-31	AU$7.70 Million ≈ $5.45 Million	AU$-4.32 Million ≈ $-3.06 Million	-0.561x	-94.62%
2018-12-31	AU$12.56 Million ≈ $8.88 Million	AU$-3.62 Million ≈ $-2.56 Million	-0.288x	--

About Microba Life Sciences Ltd

AU:MAP Australia Diagnostics & Research

Market Cap

$15.94 Million

AU$22.53 Million AUD

Market Cap Rank

#25825 Global

#1150 in Australia

Share Price

AU$0.04

Change (1 day)

-5.13%

52-Week Range

AU$0.04 - AU$0.12

All Time High

AU$0.44